itstargetnews
RADNOR, PA – January 12, 2025 (NEWMEDIAWIRE) – The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Kyverna Therapeutics , Inc. (Kyverna) (NASDAQ: KYTX) on behalf of those who purchased Kyverna common stock pursuant to and/or attributable to Kyvernas February 8, 2024 initial public offering (IPO). The lead complainant’s deadline is February 7, 2025.
CONTACT KESSLER TOPAZ MELTZER & CHECK, LLP:
If you have lost to Kyverna, you can CLICK HERE or copy and paste this link into your browser: https://www.ktmc.com/new-cases/kyverna-therapeutics-inc?utm_source=PR&utm_medium=link&utm_campaign=kytx&mktm=r
You may also contact attorney Jonathan Naji, Esq. by calling (484) 270-1453 or by email at [email protected].
DEFENDANTS ALLEGED MISCONDUCT:
The complaint alleges that, in the prospectus and registration statements issued in connection with the IPO, the Defendants made materially false and/or misleading statements and/or omissions regarding the business, operations, and company prospects. Specifically, the Defendants made false and/or misleading statements about, and/or failed to disclose, that Kyverna had adverse data related to one of its clinical trials at the time of its IPO.
THE PLAINTIFF’S PRINCIPAL PROCESS:
Kyverna investors may, no later than February 7, 2025, seek to be appointed as a lead plaintiff class representative by Kessler Topaz Meltzer & Check, LLP or other counsel, or may elect not to. ‘y will do and remain without a member of the class. The lead plaintiff is a representative party who acts on behalf of all class members in managing the litigation. The lead plaintiff is usually the investor or a small group of investors who have the largest financial interest and who are also substantial and typical of the proposed class of investors. The lead plaintiff will select an attorney to represent the lead plaintiff and the class and these attorneys, if approved by the court, will be lead or class counsel. Your ability to share in any recovery is not affected by the decision whether or not to serve as a lead plaintiff.
Kessler Topaz Meltzer & Check, LLP encourages Kyverna investors who have suffered significant losses to contact the company directly for more information.
CLICK HERE TO SIGN UP FOR A CASE OR COPY AND PASTE THIS LINK INTO YOUR BROWSER: https://www.ktmc.com/new-cases/kyverna-therapeutics-inc?utm_source=PR&utm_medium=link&utm_campaign =kytx&mktm=r
ABOUT KSSLER TOPAZ MELTZER & CHECK, LLP:
Kessler Topaz Meltzer & Check, LLP prosecutes class actions in state and federal courts nationwide and around the world. The firm has developed a global reputation for excellence and has recovered billions of dollars for victims of fraud and other corporate misconduct. All of our work is driven by one common goal: protecting investors, consumers, employees and others from fraud, abuse, misconduct and negligence by businesses and fiduciaries. The complaint in this action was not filed by Kessler Topaz Meltzer & Check, LLP. For more information about Kessler Topaz Meltzer & Check, LLP please visit www.ktmc.com.
CONTACT:
Kessler Topaz Meltzer & Check, LLP
Jonathan Naji, Esq.
(484) 270-1453
280 King of Prussia Road
Radnor, PA 19087
May be considered attorney advertising in some jurisdictions. Past results do not guarantee future results.
Copyright 2025 JCN Newswire. All rights reserved.
